Nuance Investments LLC raised its stake in Envista Holdings Co. (NYSE:NVST – Free Report) by 4.4% during the third quarter, HoldingsChannel.com reports. The institutional investor owned 7,346,534 shares of the company’s stock after acquiring an additional 308,221 shares during the period. Envista accounts for about 4.9% of Nuance Investments LLC’s holdings, making the stock its 6th biggest holding. Nuance Investments LLC’s holdings in Envista were worth $145,168,000 at the end of the most recent quarter.
Several other large investors also recently made changes to their positions in the stock. State Board of Administration of Florida Retirement System boosted its holdings in Envista by 3.1% during the first quarter. State Board of Administration of Florida Retirement System now owns 152,077 shares of the company’s stock worth $3,251,000 after purchasing an additional 4,622 shares during the last quarter. Pitcairn Co. bought a new position in shares of Envista in the 1st quarter valued at about $590,000. Ariel Investments LLC increased its position in shares of Envista by 25.3% in the first quarter. Ariel Investments LLC now owns 8,892,200 shares of the company’s stock valued at $190,115,000 after acquiring an additional 1,795,258 shares during the last quarter. Quadrature Capital Ltd raised its holdings in Envista by 110.9% during the first quarter. Quadrature Capital Ltd now owns 69,004 shares of the company’s stock worth $1,476,000 after acquiring an additional 36,290 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its position in Envista by 6.7% during the first quarter. Price T Rowe Associates Inc. MD now owns 133,887 shares of the company’s stock valued at $2,863,000 after purchasing an additional 8,380 shares during the last quarter.
Envista Stock Performance
NYSE:NVST opened at $20.26 on Wednesday. Envista Holdings Co. has a twelve month low of $15.15 and a twelve month high of $25.64. The company has a quick ratio of 1.77, a current ratio of 2.08 and a debt-to-equity ratio of 0.42. The stock’s 50-day simple moving average is $19.33 and its 200 day simple moving average is $18.12. The firm has a market capitalization of $3.49 billion, a PE ratio of -2.61, a price-to-earnings-growth ratio of 2.86 and a beta of 1.30.
Analyst Ratings Changes
NVST has been the subject of a number of recent analyst reports. Leerink Partners upgraded shares of Envista from an “underperform” rating to a “market perform” rating and increased their price target for the company from $16.00 to $23.00 in a research note on Thursday, October 31st. Evercore ISI raised their price objective on Envista from $18.00 to $23.00 and gave the company an “outperform” rating in a research report on Monday, September 23rd. Robert W. Baird boosted their target price on Envista from $17.00 to $22.00 and gave the stock a “neutral” rating in a report on Thursday, October 31st. JPMorgan Chase & Co. downgraded Envista from an “overweight” rating to a “neutral” rating and cut their price target for the company from $23.00 to $16.00 in a report on Thursday, August 8th. Finally, Bank of America reduced their target price on shares of Envista from $22.00 to $19.00 and set a “buy” rating for the company in a report on Thursday, August 8th. One analyst has rated the stock with a sell rating, eleven have given a hold rating and three have issued a buy rating to the company. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $20.71.
Read Our Latest Analysis on Envista
About Envista
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Further Reading
- Five stocks we like better than Envista
- What Investors Need to Know to Beat the Market
- 5 Dividend ETFs to Buy and Hold Forever
- Roth IRA Calculator: Calculate Your Potential Returns
- Berkshire Buys POOL Stock: Is It Time to Take the Plunge?
- Dividend Capture Strategy: What You Need to Know
- 93% Gain for Impinj Stock—Here’s Why It Could Climb Higher
Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Co. (NYSE:NVST – Free Report).
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.